Financials
- Market Capitalization 497.19 M
- Employee 674
- Founded 2013
- CEO Thomas Lingelbach
- Website www.valneva.com
- Headquarter France
- FIGI BBG00ZZPBH08
- Industry Biotechnologies
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2798 | PBYI Puma Biotechnology Inc - Common Stock | 10.42 USD | +2.96% | +5.89% | +13.88% | +95.13% | 537.88 M USD | ||
| 2825 | CTMX CytomX Therapeutics, Inc. - Common Stock | 2.23 USD | -4.29% | -12.20% | -30.31% | -35.55% | 485.92 M USD | ||
| 2848 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 7.62 USD | -4.51% | -13.80% | -29.51% | +1.20% | 473.65 M USD | ||
| 2859 | MNPR Monopar Therapeutics Inc. - Common Stock | 73.64 USD | +2.16% | -12.35% | -29.87% | +34.82% | 494.28 M USD |